查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1877426

治疗性血液分离术市场：依技术、手术类型、最终用户、应用、组件、国家及地区划分－全球产业分析、市场规模、市场份额及2025-2032年预测

Therapeutic Apheresis Market, By Technology, By Procedure Type, By End User, By Application, By Component, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 386 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年治疗性血液分离市场规模为 28.7923 亿美元，从 2025 年到 2032 年将以 4.1% 的复合年增长率成长。

治疗性血液分离术是一种医疗程序，包括抽取患者血液，对其进行处理以去除特定成分，然后再将其输回体内。治疗性血液分离术市场的主要驱动力是全球自体免疫疾病和神经系统疾病负担的日益加重，这导致临床对血浆置换和其他相关程序的需求不断增长。血液分离术在先进细胞疗法（尤其是CAR-T细胞疗法和干细胞疗法）的应用日益广泛，为设备製造商和服务提供者创造了新的收入来源。然而，设备和程序的高昂成本限制了市场成长，阻碍了中低收入国家的普及。目前，市场正快速朝向自动化、人工智慧赋能的血液分离系统转型，旨在改善患者预后、缩短手术时间并提高安全性。

治疗性血液分离市场－市场动态

慢性病盛行率上升预计将推动市场成长。

慢性病盛行率的上升预计将推动血液分离耗材和设备市场的发展。慢性病，也称为慢性疾病，是指持续时间较长（通常伴随终生）且通常无法治癒的长期健康状况。血液分离耗材和设备对于慢性病的治疗至关重要，因为它们能够针对性地去除或采集血液成分，例如用于治疗自体免疫疾病、家族性高胆固醇血症、镰状细胞贫血症以及干细胞采集等。例如，美国国家医学图书馆（一家位于美国的政府医学图书馆）预测，到2035年，美国50岁及以上成年人中将有近36%的人至少患有一种慢性病，预计到2050年，这一比例将上升至近48%。因此，慢性病盛行率的上升正在推动血液分离耗材和设备市场的发展。

治疗性血液分离术市场細項分析：

全球市场按技术、工艺类型、最终用户、应用、组件和地区进行细分。

此市场细分包含五大类：血浆置换、低密度脂蛋白（LDL）分离、白血球分离、光疗和其他。其中，血浆置换在全球血液分离市场中占有显着份额。其强劲的市场地位得益于自体免疫疾病和神经系统疾病盛行率的上升，而这又受到遗传易感性和生活方式转变的驱动。根据国际多发性硬化症联盟的数据，多发性硬化症患者人数从2020年的280万增加到2023年的290万，凸显了需要治疗介入的人不断扩大。血浆置换透过清除血液中的发炎因子、自体抗体和其他有害物质，在控制此类疾病方面发挥至关重要的作用，从而减轻疾病復发的严重程度并缩短復发持续时间。因此，医疗专业人员越来越多地将此疗法作为治疗策略的一部分，这也促进了血浆置换市场的持续成长。

从终端使用者角度来看，血库是治疗性血液分离市场中最引人注目且使用率最高的细分市场之一，这得益于其在采集、处理和供应治疗及急救所需的血液成分方面发挥的关键作用。这些机构常规进行血浆分离术、血小板分离术和白血球分离术等血液分离术，以确保为自体免疫疾病、肿瘤和血液疾病患者提供所需的特殊血液成分。其完善的基础设施、标准化的操作规程和高捐血量使其能够满足对先进血液分离系统和耗材的稳定需求。持续提升捐血者参与度和加强血液采集能力的努力进一步巩固了此细分市场的重要性。例如，2023年，新加坡榜鹅一号综合社区中心开设了一家新的血液采集中心，以满足不断增长的需求并鼓励更多人参与捐血，尤其是在年轻人中。这些发展凸显了建立强大的血液采集网络的重要性日益凸显，强调了血库为何仍然是治疗性血液分离领域中一个重要且快速发展的组成部分。

治疗性血液分离市场—地域性洞察

北美在全球血液分离术市场占有显着份额。慢性病在北美国家十分普遍，血液系统疾病患者族群庞大。例如，全球癌症观察站估计，2022年北美将新增约7.17万例白血病病例。同样，美国疾病管制与预防中心（CDC）报告称，2023年镰状细胞疾病（SCD）影响约10万美国人。这凸显了对最佳治疗方案的需求，从而推动了北美血液分离术市场的发展。此外，这些国家的人均消费水准不断提高，导致医疗支出显着成长。随着经济成长加速，越来越多的人选择先进的治疗方法，进一步促进了市场成长。

美国治疗性血液分离市场—国家概况

美国是该地区的主要市场。美国老年人口的成长正在推动市场成长。随着人口老化，癌症和慢性病病例可能会增加。这一因素将有助于推动区域市场成长。血液相关疾病（如肾臟病、代谢性疾病、癌症和神经系统疾病）负担日益加重，完善的医疗保健基础设施以及患者较高的健康意识是推动北美研究市场成长的主要因素。根据白血病和淋巴瘤协会 (LLS) 统计，美国每三分钟就有一人被诊断出患有血液癌症。 2020 年，美国约有 178,520 人被诊断出罹患白血病、淋巴瘤或骨髓瘤。 2021 年，白血病、淋巴瘤和骨髓瘤占美国 1,898,160 例新确诊癌症病例的 9.8%。因此，目标疾病的高发生率推动了市场成长。

治疗性血液分离术市场—竞争格局：

治疗性血液分离术市场竞争格局较为集中，创新、技术整合和流程效率在差异化竞争中扮演重要角色。该领域的企业主要透过开发先进的血液分离系统来展开竞争，这些系统能够提高自动化程度、增强安全性并缩短手术时间。耗材、服务合约和培训计画是竞争策略的关键组成部分，因为医疗机构越来越倾向于选择能够提供全面营运支援的供应商。市场参与者也致力于拓展适应症，例如自体免疫疾病、神经系统疾病和细胞疗法等应用，以提高临床相关性和市场接受度。监管部门的批准、循证临床资料以及与数位监测平台的整合有助于企业确立竞争优势。

目录

第一章：治疗性血液分离术市场概览

  • 研究范围
  • 市场估算年份

第二章：执行概要

  • 市集
    • 按技术分類的治疗性血液分离市场概览
    • 按手术类型分類的治疗性血液分离市场概览
    • 按最终用户分類的治疗性血液分离市场概览
    • 按应用领域分類的治疗性血液分离市场概览
    • 治疗性血液分离市场按组件分類的概览
    • 各国治疗性血液分离术市场概况
    • 治疗性血液分离术市场概览（按地区划分）
  • 竞争洞察

第三章：治疗性血液分离术的关键市场趋势

  • 治疗性血液分离术市场驱动因素
    • 市场驱动因素的影响分析
  • 治疗性血液分离术市场限制因素
    • 市场限制因素的影响分析
  • 治疗性血液分离术市场机会
  • 治疗性血液分离术市场未来趋势

第四章：治疗性血液分离术产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景分析
  • 规范架构分析

第五章：治疗性血液分离术市场：地缘政治紧张局势升级的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：治疗性血液分离术市场概况

  • 2024年治疗性血液分离市占率分析
  • 主要製造商细分数据
    • 知名球员分析
    • 新兴参与者分析

第七章：治疗性血液分离市场－依技术划分

  • 概述
    • 按技术分類的细分市场份额分析
    • 离心
    • 薄膜过滤

第八章：治疗性血液分离术市场－依手术类型划分

  • 概述
    • 依程序类型进行细分份额分析
    • 治疗性血浆置换（TPE）
    • 细胞耗竭
    • 红血球置换（RBCX）
    • 其他程式

第九章：治疗性血液分离市场－以最终用户划分

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 专科诊所
    • 血库
    • 门诊手术中心

第十章：治疗性血液分离市场－依应用领域划分

  • 概述
    • 依程序类型进行细分份额分析
    • 神经病学
    • 肿瘤学
    • 镰形血球贫血症
    • 自体免疫疾病
    • 移植物抗宿主疾病（GVHD）
    • 肾臟病学
    • 家族性高胆固醇血症
    • 实体器官移植

第十一章：治疗性血液分离市场－按组件划分

  • 概述
    • 按组成部分分類的细分市场占有率分析
    • 血浆置换
    • 低密度脂蛋白分离术
    • 白血球分离术
    • 光疗
    • 其他的

第十二章：治疗性血液分离术市场－依地理划分

  • 介绍
    • 按地域分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美治疗性血液分离术钥匙製造商
    • 北美市场规模及预测（按国家/地区划分）
    • 北美市场规模及预测（依技术划分）
    • 北美市场规模及预测（依手术类型划分）
    • 北美市场规模及预测（依最终用户划分）
    • 北美市场规模及预测（按应用划分）
    • 北美市场规模及预测（按组件划分）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲治疗性血液分离术关键设备製造商
    • 欧洲市场规模及预测（按国家/地区划分）
    • 欧洲市场规模及预测（依技术划分）
    • 欧洲市场规模及预测（依手术类型划分）
    • 欧洲市场规模及预测（依最终用户划分）
    • 欧洲市场规模及预测（按应用领域划分）
    • 欧洲市场规模及预测（按组件划分）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区
    • 概述
    • 亚太地区治疗性血液分离术关键设备製造商
    • 亚太市场规模及预测（依国家/地区划分）
    • 亚太市场规模及预测（依技术划分）
    • 亚太市场规模及预测（依手术类型划分）
    • 亚太市场规模及预测（依最终用户划分）
    • 亚太市场规模及预测（按应用划分）
    • 亚太市场规模及预测（依组件划分）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲治疗性血液分离术钥匙製造商
    • 拉丁美洲市场规模及预测（按国家/地区划分）
    • 拉丁美洲市场规模及预测（依技术划分）
    • 拉丁美洲市场规模及预测（依手术类型划分）
    • 拉丁美洲市场规模及预测（按最终用户划分）
    • 拉丁美洲市场规模及预测（按应用划分）
    • 拉丁美洲规模及预测（按组成部分）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲治疗性血液分离术关键製造商
    • 中东和非洲市场规模及预测（按国家/地区划分）
    • 中东和非洲市场规模及预测（按技术划分）
    • 中东和非洲市场规模及预测（按手术类型划分）
    • 中东和非洲市场规模及预测（按最终用户划分）
    • 中东和非洲市场规模及预测（按应用划分）
    • 中东和非洲市场规模及预测（按组件划分）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 中东和非洲其他地区

第十三章：主要供应商分析－治疗性血液分离术产业

  • 竞争基准化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司简介
    • Baxter Healthcare Corporation
    • Kawasumi Laboratories Inc.
    • Therakos Incorporation
    • Mallinckrodt Plc
    • Asahi Kasei Medical Co.
    • Haemonetics Corporation
    • Miltenyi Biotec
    • Terumo BCT
    • Asahi Kasei Medical
    • B. Braun Melsungen AG
    • Nikkiso Co. Ltd.
    • Cerus Corporation
    • Terumo BCT Inc.
    • Fresenius Kabi USA
    • Medica SpA
    • Others

第十四章：360度分析师视角

第十五章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5751

The Therapeutic Apheresis Market size was valued at US$ 2,879.23 Million in 2024, expanding at a CAGR of 4.1% from 2025 to 2032.

Therapeutic apheresis is a medical procedure that involves drawing blood from a patient, processing it to remove specific components, and then returning it to the body. The Therapeutic Apheresis market is primarily driven by the growing global burden of autoimmune and neurological disorders, which is increasing clinical demand for plasma exchange and other procedures. The growing use of apheresis in advanced cell therapies, particularly CAR-T and stem-cell treatments, presents a significant opportunity for device manufacturers and service providers to generate new revenue streams. However, market growth is constrained by the high cost of equipment and procedures, preventing widespread adoption in low- and middle-income countries. The market is being shaped by a rapid shift toward automated, AI-enabled apheresis systems designed to improve patient outcomes, reduce procedure time, and increase safety.

Therapeutic Apheresis Market- Market Dynamics

Rise In Chronic Conditions Is Anticipated To Fuel The Market Growth

The rise in chronic conditions is expected to drive the apheresis consumables and equipment market forward. Chronic conditions, also known as chronic diseases, are long-term health conditions that persist for an extended period of time, often for the rest of a person's life, and are typically incurable. Apheresis consumables and equipment are critical for managing chronic diseases because they allow for the targeted removal or collection of blood components in conditions such as autoimmune disorders, familial hypercholesterolemia, sickle cell disease, and stem cell harvest. For instance, the National Library of Medicine, a government medical library based in the United States, predicts that by 2035, nearly 36% of US adults aged 50 and older will have at least one chronic condition, with that figure expected to rise to nearly 48% by 2050. As a result, the rise in chronic conditions is propelling the apheresis consumables and equipment market.

Therapeutic Apheresis Market- Segmentation Analysis:

The worldwide market is segmented on the basis of Technology, Procedure Type, End User, Application, Component, and Region.

The component segmentation, which comprises five major groups, Plasmapheresis, LDL Apheresis, Leukapheresis, Photopheresis, and Others. Among this, plasmapheresis accounted for a significant share of the Global Apheresis Market. Its strong position is supported by the rising prevalence of autoimmune and neurological disorders, driven by genetic predispositions and shifting lifestyle patterns. According to the Multiple Sclerosis International Federation, the number of people living with Multiple Sclerosis increased from 2.8 million in 2020 to 2.9 million in 2023, highlighting the expanding population requiring therapeutic interventions. Plasmapheresis plays a vital role in managing such conditions by removing inflammatory agents, autoantibodies, and other damaging substances from the bloodstream, leading to reduced severity and duration of disease relapses. As a result, healthcare professionals are increasingly recommending this procedure as part of treatment strategies, contributing to the continued growth of the plasmapheresis segment.

Based on End-User segment, Blood banks are one of the most visible and highly utilized segments in the Therapeutic Apheresis Market, owing to their critical role in collecting, processing, and supplying blood components required for therapeutic and emergency medical purposes. These facilities routinely perform apheresis procedures, such as plasmapheresis, plateletpheresis, and leukapheresis, to ensure the availability of specialized blood components for patients suffering from autoimmune, oncological, and hematological diseases. Their established infrastructure, standardized operating protocols, and high donor throughput allow them to meet the steady demand for advanced apheresis systems and consumables. The segment's importance is bolstered by ongoing efforts to increase donor engagement and strengthen blood collection capacity. For instance, in 2023, a new blood collection center was opened at Singapore's One Punggol integrated community hub to meet rising demand and encourage increased donor participation, particularly among young people. Such developments highlight the growing emphasis on establishing strong blood-collection networks, emphasizing why blood banks remain an important and rapidly expanding component of the therapeutic apheresis landscape.

Therapeutic Apheresis Market- Geographical Insights

North America holds a prominent market share in the global apheresis market. Chronic diseases are common in North American countries, and there is a large patient population suffering from hematological diseases. For instance, the Global Cancer Observatory estimates that approximately 71.7 thousand new cases of leukemia will be reported in North America in 2022. Similarly, the Centers for Disease Control and Prevention (CDC) reported in 2023 that sickle cell disease (SCD) affects approximately 100,000 Americans. This necessitates the need for the best therapeutic solutions, which drives the North American Apheresis Market. Furthermore, the per capita consumption in these countries is increasing, resulting in significant growth in health expenditure. Individuals are increasingly opting for advanced therapies as economic growth accelerates, boosting market growth.

United States Therapeutic Apheresis Market- Country Insights

The United States is the region's major market. The increasing geriatric population in the United States is driving market growth. As the population ages, more cancer cases and chronic diseases are likely to emerge. This factor will help to drive regional market growth. The growing burden of blood-related ailments such as kidney disease, metabolic diseases, cancer, and neurological disorders, the presence of established healthcare infrastructure, and high patient awareness levels are the primary factors driving the growth of the studied market in North America. According to the Leukemia & Lymphoma Society (LLS), someone in the United States is diagnosed with blood cancer every three minutes. Approximately 178,520 people in the United States were diagnosed with leukemia, lymphoma, or myeloma in 2020. Leukemia, lymphoma, and myeloma accounted for 9.8% of the 1,898,160 new cancer cases diagnosed in the United States in 2021. As a result, the high incidence of target diseases drives the market's growth.

Therapeutic Apheresis Market- Competitive Landscape:

The therapeutic apheresis market has a moderately consolidated competitive environment, with innovation, technology integration, and procedural efficiency playing important roles in differentiation. Companies in this space compete primarily by developing advanced apheresis systems that provide increased automation, improved safety profiles, and shorter procedure times. Consumables, service contracts, and training programs are critical components of competitive strategy, as healthcare facilities increasingly prefer vendors who provide comprehensive operational support. Market participants are also focusing on expanding indications, such as autoimmune, neurological, and cell-therapy applications, to increase clinical relevance and adoption. Regulatory approvals, evidence-based clinical data, and integration with digital monitoring platforms help to define competitive advantages.

Recent Developments:

In August 2023, TERUMO BCT, INC received FDA approval for a groundbreaking platelet device that converts blood into platelets in a single centrifugation cycle, increasing the speed and reliability of blood component preparation.

In August 2023, Fresenius Kabi AG and Lupagen Inc. have signed a new supply and development agreement. This collaboration focuses on developing technologies to improve the delivery of cell and gene therapies directly to patients in clinical settings.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL THERAPEUTIC APHERESIS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Baxter Healthcare Corporation
  • Kawasumi Laboratories Inc.
  • Therakos Incorporation
  • Mallinckrodt Plc
  • Asahi Kasei Medical Co.
  • Haemonetics Corporation
  • Miltenyi Biotec
  • Terumo BCT
  • Asahi Kasei Medical
  • B. Braun Melsungen AG
  • Nikkiso Co. Ltd.
  • Cerus Corporation
  • Terumo BCT Inc.
  • Fresenius Kabi USA
  • Medica S.p.A.
  • Others

GLOBAL THERAPEUTIC APHERESIS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Centrifugation
  • Membrane filtration

GLOBAL THERAPEUTIC APHERESIS MARKET, BY PROCEDURE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Therapeutic plasma exchange (TPE)
  • Cellular depletions
  • Red blood cell exchange (RBCX)
  • Other procedures

GLOBAL THERAPEUTIC APHERESIS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Specialty clinics
  • Blood banks
  • Ambulatory surgical centers

GLOBAL THERAPEUTIC APHERESIS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Neurology
  • Oncology
  • Sickle cell disease
  • Autoimmune disease
  • Graft-versus-host disease (GVHD)
  • Nephrology
  • Familial hypercholesterolemia
  • Transplant of solid organs

GLOBAL THERAPEUTIC APHERESIS MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Plasmapheresis
  • LDL Apheresis
  • Leukapheresis
  • Photopheresis
  • Others

GLOBAL THERAPEUTIC APHERESIS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Therapeutic Apheresis Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Therapeutic Apheresis Market Snippet by Technology
    • 2.1.2. Therapeutic Apheresis Market Snippet by Procedure Type
    • 2.1.3. Therapeutic Apheresis Market Snippet by End User
    • 2.1.4. Therapeutic Apheresis Market Snippet by Application
    • 2.1.5. Therapeutic Apheresis Market Snippet by Component
    • 2.1.6. Therapeutic Apheresis Market Snippet by Country
    • 2.1.7. Therapeutic Apheresis Market Snippet by Region
  • 2.2. Competitive Insights

3. Therapeutic Apheresis Key Market Trends

  • 3.1. Therapeutic Apheresis Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Therapeutic Apheresis Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Therapeutic Apheresis Market Opportunities
  • 3.4. Therapeutic Apheresis Market Future Trends

4. Therapeutic Apheresis Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Therapeutic Apheresis Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Therapeutic Apheresis Market Landscape

  • 6.1. Therapeutic Apheresis Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Therapeutic Apheresis Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 7.1.2. Centrifugation
    • 7.1.3. Membrane filtration

8. Therapeutic Apheresis Market - By Procedure Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Procedure Type, 2024 & 2032 (%)
    • 8.1.2. Therapeutic plasma exchange (TPE)
    • 8.1.3. Cellular depletions
    • 8.1.4. Red blood cell exchange (RBCX)
    • 8.1.5. Other procedures

9. Therapeutic Apheresis Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Specialty clinics
    • 9.1.4. Blood banks
    • 9.1.5. Ambulatory surgical centers

10. Therapeutic Apheresis Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Procedure Type, 2024 & 2032 (%)
    • 10.1.2. Neurology
    • 10.1.3. Oncology
    • 10.1.4. Sickle cell disease
    • 10.1.5. Autoimmune disease
    • 10.1.6. Graft-versus-host disease (GVHD)
    • 10.1.7. Nephrology
    • 10.1.8. Familial hypercholesterolemia
    • 10.1.9. Transplant of solid organs

11. Therapeutic Apheresis Market - By Component

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
    • 11.1.2. Plasmapheresis
    • 11.1.3. LDL Apheresis
    • 11.1.4. Leukapheresis
    • 11.1.5. Photopheresis
    • 11.1.6. Others

12. Therapeutic Apheresis Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Therapeutic Apheresis Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Therapeutic Apheresis Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Therapeutic Apheresis Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Therapeutic Apheresis Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Therapeutic Apheresis Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Therapeutic Apheresis Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Baxter Healthcare Corporation
    • 13.2.2. Kawasumi Laboratories Inc.
    • 13.2.3. Therakos Incorporation
    • 13.2.4. Mallinckrodt Plc
    • 13.2.5. Asahi Kasei Medical Co.
    • 13.2.6. Haemonetics Corporation
    • 13.2.7. Miltenyi Biotec
    • 13.2.8. Terumo BCT
    • 13.2.9. Asahi Kasei Medical
    • 13.2.10. B. Braun Melsungen AG
    • 13.2.11. Nikkiso Co. Ltd.
    • 13.2.12. Cerus Corporation
    • 13.2.13. Terumo BCT Inc.
    • 13.2.14. Fresenius Kabi USA
    • 13.2.15. Medica S.p.A.
    • 13.2.16. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us